Since the identification of the disease-associated gene SMN1 in 1995 [2], the drive to uncover the mechanisms underlying SMA pathogenesis has been complicated by the pleiotropic nature of the SMN locus [3], coupled with the varied levels of SMN protein in human and animal models [4–6]. Here, SMN1 is linked to proximal spinal muscular atrophy.